Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure
医学
阿司匹林
心力衰竭
心室辅助装置
内科学
心脏病学
重症监护医学
作者
Mandeep R. Mehra,Ivan Netuka,Nir Uriel,Jason N. Katz,Francis D. Pagani,Ulrich P. Jorde,Finn Gustafsson,Jean M. Connors,Peter Ivák,Jennifer Cowger,John Ransom,Aditya Bansal,Koji Takeda,Richa Agarwal,Mirnela Byku,Michael M. Givertz,Abbas Bitar,Shelley Hall,Daniel Zimpfer,J. David Vega
出处
期刊:JAMA [American Medical Association] 日期:2023-11-11卷期号:330 (22): 2171-2171被引量:72
Left ventricular assist devices (LVADs) enhance quality and duration of life in advanced heart failure. The burden of nonsurgical bleeding events is a leading morbidity. Aspirin as an antiplatelet agent is mandated along with vitamin K antagonists (VKAs) with continuous-flow LVADs without conclusive evidence of efficacy and safety.